Biobase Immunoassay Analyzer, Bki2200 Immunoanalyzer, Clia Chemiluminescence Testing System

Name: Biobase Immunoassay Analyzer, Bki2200 Immunoanalyzer, Clia Chemiluminescence Testing System
Brand: Biobase Biolin Co., Ltd.
SKU: 2031973845

Shandong, ChinaBiobase Biolin Co., Ltd.

US$8,900.00-16,580.00

1 unit

Product profile

Customization

Available

Classification

Imaging Diagnostic Equipment

Type

Biochemistry Analyzer

Model NO.

BKI1100

Group

All

Model

Bki1100

Throughput

180t/H

Principle

Magnetic Particle Enzymatic Chemiluminescence

Modes of Operation

Random, Batch and Stat

Separation Method

Magnetic Separation Technology

Sample Positions

60 (Each Position Could Be Used as an Emergency Po

Reagent Positions

25 PCS (2-8℃ Refrigeration)

Incubation Positions

Time to 1st Result

18 Minutes

Calibration Type

6/7-Point Calibration

Sample Volume

10-200μl

Detection Precision

CV≤5%

Correlation Coefficient

R≥0.99

Calibration Stability

28 Days

Transport Package

Wooden Case or Carton Box

Specification

1303*873*854mm/180kg

Trademark

BIOBASE

Origin

China

HS Code

9027899090

Production Capacity

10000

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceMulti-language PioneerExperienced Team

Biobase Biolin Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8.5 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.60h

AI-Powered supplier vetting

SummaryThe supplier is identified as a limited trading company in Jinan, offering laboratory equipment, medical devices, biochemistry analyzers, autoclaves, biological safety cabinets, and related products. It reports ODM, OEM, professional technical, 3D design, and flexible customization capabilities, along with overseas service offerings and a stated export-sales share of 90%. Service procedures are mixed: complaint handling and corrective/preventive action procedures have records, while effective service-capability assessment procedures lack written procedures and records. No overseas showroom, agent, branch, offline trade-show participation, SDK, or new-product launch is reported. Production quantities are stated for three products, but the supplier’s manufacturing status is unclear because it is classified as a trading company.

Supplier typeThe supplier is explicitly classified as a Trading Company and Limited Company, with a business scope centered on sales of medical equipment, office supplies, software, electronic products, and related items. It is not identified as part of a larger company group, and its associated industry is wholesale and retail.

After-Sales capabilityThe supplier reports overseas training, equipment installation, repair, maintenance, and debugging services, with 10 qualified service suppliers and stated lead times of within 15 working days off-season and one month during peak season. Complaint handling and corrective/preventive-action procedures have records, but the assessment procedure for effective service capability lacks written procedures and records; there are also no overseas showrooms, agents, branches, or offline trade-show experience.

R&D capabilityThe supplier reports ODM service, professional technical R&D capability, 3D software design, and flexible customization. However, it reports no new products launched in the past year and no available SDK, while product-information R&D capability is also marked as absent.

Customization capabilityThe supplier explicitly provides ODM services, 3D software design services, and flexible customization through its design and R&D capabilities. These statements directly support the availability of customized design or product solutions.